Back to Authors

Bercik, Premysl

0000-0001-8707-1781

Mayo Clinic

Farncombe Family Digestive Health Research Institute - McMaster University, Hamilton, ON, Canada.

Citations 2

Small intestinal microbial fiber metabolism dysfunction in celiac disease
Verdú, Elena F. , Wulczynski, Mark, Blom, Jedid-Jah , Rueda, Gaston , El-Chaar, Nader N., Superdock, Dorothy K. , Jiang, Sharon, David, Lawrence A. , Armstrong, David , Berčík, Přemysl , El-Chaar, N , Superdock, D K , David, L A , Surette, M G , Bercik, Premysl , Caminero, A , Verdu, Elena F , Constante, Marco , Galipeau, Heather J. , Rueda, Gaston H., Murray, Joseph A. , Armstrong, David , Pinto-Sánchez, María Inés , Caminero, Alberto

No container title available | May 12, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-6572358/v1 Get It

Abstract Celiac disease (CeD) is an immune-mediated condition driven by dietary gluten resulting in small intestinal mucosal inflammation and injury, along with myriads of symptoms. The only treatment is a lifelong gluten-free diet (GFD) and although most patients improve, the restriction can lead to nutrient deficiencies including fiber. While duodenal microbiota is altered in CeD, its fiber metabolic capacity is unknown. Here we show that both active and GFD-treated CeD patients had impaired microbial fiber metabolism in the small intestine which associates with depletion of the carbolytic taxa Prevotella spp. Colonization of germ-free mice with Prevotella spp increased small intestinal short chain fatty acids (SCFA). In gluten-sensitized mice expressing the celiac risk gene, HLA-DQ8, an inulin-supplemented diet facilitated microbial carbolytic function, SCFAs production and accelerated mucosal healing in the small intestine during GFD. The results support clinical investigations of dietary fiber supplementation and microbial carbolytic function to enhance responses to GFD in CeD.
Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation
Lamas, Bruno , Hernández-Galán, Leticia, Galipeau, Heather J. , Constante, Marco , Clarizio, Alexandra , Jury, Jennifer , Breyner, Natália Martins , Caminero, Alberto , Rueda, Gaston , Hayes, Christina L. , Brito, Miriam Bermudez, Planchais, Julien , Rolhion, Nathalie , Loonen, Linda M. P. , Wells, Jerry M. , Berčík, Přemysl , Sokol, Harry , Verdú, Elena F. , Breyner, Natalia M , Planchais, Julien , Loonen, Linda M P , Bercik, Premysl , Sokol, Harry , Verdu, Elena F , Caminero, A , McCarville, Justin L. , Murray, Joseph A. , Langella, Philippe

Science Translational Medicine | October 21, 2020 | Volume: 12 | Issue: 566 | Pages: No page available

10.1126/scitranslmed.aba0624 Get It

Impaired AhR ligand production by the gut microbiota decreases AhR pathway activation, promoting inflammation in celiac disease.